Investigating the Next Wave of Innovation to Help People with Hemophilia
Watch below.
Menstrual Migraine Explained: Why They Happen and What Can Help
For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.
Menstrual Migraine Explained: Why They Happen and What Can Help
For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Menstrual Migraine Explained: Why They Happen and What Can Help
For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.
Menstrual Migraine Explained: Why They Happen and What Can Help
For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.